BUENA, N.J., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty
generic pharmaceutical company, will be presenting at the J.P. Morgan 36th Annual Healthcare Conference. The Conference
is taking place January 8-11, 2018 at the Westin St. Francis Hotel, San Francisco, CA.
Jason Grenfell-Gardner, President and CEO and Jenniffer Collins, Chief Financial Officer of Teligent, Inc. will
present on Wednesday, January 10, 2018 at 11:00 a.m. PT.
The presentation will be webcast and will be accessible online on the investors section of the Company's website
at http://www.teligent.com. A replay will be available for 30 days.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty
generic prescription drug market. Learn more on our website www.teligent.com.
Contact:
Jenniffer Collins
Teligent, Inc.
(856) 697-4379
www.teligent.com
